Therapeutic strategies using inhibitors of angiogenesis.
O'Reilly
Michael S
MS
Department of Radiation Oncology and Cancer Biology, M.D. Anderson Cancer Center, University of Texas, Houston, USA.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D010450:Endopeptidases / Q000494:pharmacology; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009389:Neovascularization, Pathologic; D019714:Tissue Inhibitor of Metalloproteinases / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D010450:Endopeptidases